Tissue factor pathway inhibitor: from unknown coagulation inhibitor to major antithrombotic principle.
Lindahl
A K
AK
Department of Vascular Surgery, University of Oslo, Aker Hospital, Norway.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D065427:Factor Xa Inhibitors; D006801:Humans; D008074:Lipoproteins / Q000502:physiology* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D008074:Lipoproteins; D011994:Recombinant Proteins; C051928:lipoprotein-associated coagulation inhibitor